BMRN 65.66 (+1.02%)
US09061G1013• Biotechnology• Biotechnology
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. BMRN

Biomarin Pharmaceutical (BMRN) Stories

Here is a selected set of our story library related to Biomarin Pharmaceutical (BMRN).

Post

Biomarin Pharmaceutical (BMRN) - Piotroski F-Score Analysis for Year 2023 (Final Score: 6/9)

Detailed Piotroski F-Score analysis of BioMarin Pharmaceutical (BMRN) for 2023, scored 6/9. Insights on profitability, liquidity, and operational metrics.

2024-06-07